A program that balances scientific advances and cost, oncology clinical pathways can be an important tool for improving quality of care.
Jennifer Gershman, PharmD, CPh
Pain management drugs in phase 3 development show promise as abuse-deterrent formulations of opioid therapies.
Phase 3 drugs show innovative approaches to cancer treatment.
MS is in need of new medications—these could be the future.